Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Orion Laboratories Pty Ltd T/A Perrigo Australia

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (279)
ARTG (50)
Cancellation or suspension (26)
COVID-19 disinfectant (4)
Australian Public Assessment Report (AusPAR) (1)
Listed medicine compliance report (1)
Prescription medicine registration (1)

Date

2024 (10)
2023 (22)
2022 (32)
2021 (14)
2020 (13)
2019 (91)
2018 (21)
2017 (40)
2016 (1)
2015 (76)
2014 (1)
2013 (1)
2009 (3)
2008 (5)
2007 (2)
1992 (3)
1991 (23)

Results for "[search-keyword]"

Search

Sponsor content

362 result(s) found, displaying 41 to 50

WOOLWORTHS SELECT IBUPROFEN ibuprofen lysine 342mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Orion Laboratories Pty Ltd T/A Perrigo Australia
DISCOUNT DRUG PARACETAMOL & CAFFEINE film coated tablet bottle Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Orion Laboratories Pty Ltd T/A Perrigo Australia
Suspended from ARTG - ORION RANITIDINE 150mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Orion Laboratories Pty Ltd T/A Perrigo Australia
Suspended from ARTG - CHEMPLUS RANITIDINE COOL MINT COATED 150mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Orion Laboratories Pty Ltd T/A Perrigo Australia
PHARMACY DIRECT PARACETAMOL paracetamol 500mg film coated tablets bottle Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Orion Laboratories Pty Ltd T/A Perrigo Australia
MEDIHEALTH PARACETAMOL paracetamol 500mg film coated tablets bottle Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Orion Laboratories Pty Ltd T/A Perrigo Australia
MEDIHEALTH IBUPROFEN ibuprofen 200mg tablet bottle Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Orion Laboratories Pty Ltd T/A Perrigo Australia
YOUR PHARMACY CHESTY COUGH & COLD RELIEF capsule blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Orion Laboratories Pty Ltd T/A Perrigo Australia
YOUR PHARMACY CHESTY COUGH & COLD RELIEF HOT DRINK oral powder sachet Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Orion Laboratories Pty Ltd T/A Perrigo Australia
YOUR PHARMACY COLD & FLU HOT DRINK PE oral powder sachet Cancelled under Section 30(1)(c) of the Act

27 June 2022

Cancellation by sponsor

Requested by Orion Laboratories Pty Ltd T/A Perrigo Australia

Pages

First page
Previous page
Page 1
Page 2
Page 3
Page 4
Current page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.